Sao Tome and Principe vs Syria: HIV-positive TB patients on ART (antiretroviral therapy)
Sao Tome and Principe
100.0%
in 2024
Syria
100.0%
in 2021
Sao Tome and Principe rank
1st
Syria rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Sao Tome and Principe
- Syria
How they compare
Sao Tome and Principe currently reports 100.0% against 100.0% in Syria, a difference of 0.0%.
Across all 11 years both countries report, Syria has been ahead every year.
Sao Tome and Principe ranks 1st and Syria ranks 1st of 144 countries.
Syria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sao Tome and Principe | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.0% | 100.0% | 78.0% | Syria |
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Sao Tome and Principe or Syria?
- Sao Tome and Principe, at 100.0% against 100.0% in Syria as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Sao Tome and Principe and Syria?
- 0.0%, with Sao Tome and Principe ahead.
- How many years of comparable data are there for Sao Tome and Principe and Syria?
- 11 years are reported by both, from 2007 to 2021.
- How do Sao Tome and Principe and Syria rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Sao Tome and Principe ranks 1st and Syria ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.